Reproduced with permission from David Arterburn, Lesley H. Curtis, Sengwee Toh, et al. Leveraging Real-World Evidence to Inform Regulatory, Clinical, and Coverage Decisions Related to Glucagon-Like Peptide-1–Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop. Annals of Internal Medicine. Epub 30 June 2026. doi:10.7326/ANNALS-25-05468. ©American College of Physicians.
